Both FSTL1 and adiponectin independently correlated with metabolic syndrome (P < 0.001, odds ratio 1.039, 95% CI 1.025–1.054; P < 0.001, odds ratio 0.979, 95% CI 0.971–0.988, respectively). Here, ADIPOQ is linked to metabolic syndrome.